Protagonist Therapeutics Inc (PTGX)
Healthcare
Biotechnology
132.30 $
-3.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Protagonist Therapeutics Inc (PTGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -49 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -26 | -27 | 17 | -27 | 269 | -28 | -29 | 125 | -29 | -1.9 | -37 | -49 | -117 | |
| 0.8 | 0.8 | 0.8 | 0.2 | 1.5 | 0.6 | 0.5 | 0.2 | 0.3 | 0.4 | -0.9 | 0.4 | 0.2 | |
| 8.3 | 6.8 | 6.6 | 9.4 | 8.9 | 10 | 9.1 | 14 | 11 | 11 | 11 | 15 | 47 | |
| 8.3 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 4.0 | 0.9 | -16 | -243 | 291 | -2.6 | -168 | 125 | -3.9 | 28 | -2.7 | -67 | -46 | |
| 0.2 | 0.4 | 0.0 | 0.2 | 0.0 | 0.8 | 0.3 | 0.5 | 0.8 | 0.1 | 1.4 | 0.2 | 2.6 | |
| 26 | -14 | -61 | 6.1 | -88 | -209 | -8.7 | -94 | 55 | -59 | 49 | 91 | 136 | |
| -0.7 | – | 0.8 | -0.6 | – | 0.6 | – | – | – | – | – | – | – | |
| 108 | 35 | 0.5 | 7.2 | 2.6 | 12 | 4.0 | 11 | 2.9 | 5.7 | 2.8 | 23 | 35 | |
| 108 | -4.9 | -44 | -14 | 183 | -225 | -34 | 42 | 29 | -55 | 15 | 65 | 54 | |
| -26 | -27 | 17 | -28 | 269 | -29 | -29 | 125 | -30 | -2.0 | -36 | -49 | -116 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.